Back to search

The role of tumor stroma in the interaction between tumor and immune system

Data up to Jan 2025

Published2005
Citations179
References59

Total Citations Per Year

Abstract

References (59)

The Hallmarks of Cancer

2000 • 27,569 citations

Inflammation and cancer

2002 • 14,174 citations

Inflammation. Basic principles and clinical correlates

1989 • 2,424 citations

Putting tumours in context

2001 • 2,145 citations

Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy

2001 • 1,556 citations

Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium

2000 • 1,445 citations

TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

2004 • 1,346 citations

Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

2003 • 919 citations

Stromal Effects on Mammary Gland Development and Breast Cancer

2002 • 902 citations

Murine interleukin-4 displays potent anti-tumor activity in vivo

1989 • 790 citations

Inflammation: Basic Principles and Clinical Correlates

2000 • 616 citations

Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation

2001 • 554 citations

CD4 + T Cell–Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFNγ Receptor Expression by Nonhematopoietic Cells

2000 • 505 citations

Decreased tumor surveillance in perforin-deficient mice.

1996 • 487 citations

Distinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo

1999 • 445 citations

Know thy neighbor: stromal cells can contribute oncogenic signals

2001 • 422 citations

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.

1990 • 417 citations

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

1991 • 402 citations

Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages.

1984 • 366 citations

Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine

2001 • 307 citations

Bystander elimination of antigen loss variants in established tumors

2004 • 259 citations

Inhibition of Angiogenesis by Interleukin 4

1998 • 254 citations

Increasing Tumor Antigen Expression Overcomes “Ignorance” to Solid Tumors via Crosspresentation by Bone Marrow-Derived Stromal Cells

2002 • 239 citations

Immunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells

2003 • 229 citations

A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells.

2003 • 227 citations

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.

1993 • 221 citations

Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis.

1994 • 188 citations

Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay

2001 • 152 citations

Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.

1996 • 151 citations

Tumor Rejection by Disturbing Tumor Stroma Cell Interactions

2001 • 147 citations

Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts

1993 • 146 citations

Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration.

1993 • 140 citations

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

2001 • 130 citations

Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin

2002 • 128 citations

CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction

2004 • 126 citations

The role of IFN-γ in tumor transplantation immunity and inhibition of chemical carcinogenesis

2003 • 121 citations

Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts

2002 • 107 citations

IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy

2001 • 106 citations

Immunoprevention of Mammary Carcinoma in HER-2/neu Transgenic Mice Is IFN-γ and B Cell Dependent

2004 • 91 citations

Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor

2000 • 84 citations

Tumor Regression After Adoptive Transfer of Effector T Cells Is Independent of Perforin or Fas Ligand (APO-1L/CD95L)

1999 • 82 citations

Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells

2003 • 78 citations

TNF Plays an Essential Role in Tumor Regression after Adoptive Transfer of Perforin/IFN-γ Double Knockout Effector T Cells

2003 • 77 citations

A Spontaneously Arising Pancreatic Tumor Does Not Promote the Differentiation of Naive CD8+ T Lymphocytes into Effector CTL

2004 • 74 citations

Tumor Necrosis Factor Induces Tumor Necrosis via Tumor Necrosis Factor Receptor Type 1-Expressing Endothelial Cells of the Tumor Vasculature

2000 • 67 citations

The paracrine role of tumour-derived mIL-4 on tumour-associated endothelium

1997 • 54 citations

Differential requirement of perforin and IFN-γ in CD8 T cell-mediated immune responses against B16.F10 melanoma cells expressing a viral antigen

2000 • 51 citations

Immunotherapy of Melanoma: A Dichotomy in the Requirement for IFN-γ in Vaccine-Induced Antitumor Immunity Versus Adoptive Immunotherapy

2001 • 51 citations

Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection.

1998 • 50 citations

T Cell-Mediated Tumor Rejection Displays Diverse Dependence Upon Perforin and IFN-γ Mechanisms That Cannot Be Predicted From In Vitro T Cell Characteristics

2000 • 47 citations

Role of Effector Cell-Derived IL-4, IL-5, and Perforin in Early and Late Stages of Type 2 CD8 Effector Cell-Mediated Tumor Rejection

2001 • 46 citations

The Rate of the CD8-Dependent Initial Reduction in Tumor Volume Is Not Limited by Contact-Dependent Perforin, Fas Ligand, or TNF-Mediated Cytolysis

2004 • 42 citations

Tumor Rejection by Modulation of Tumor Stromal Fibroblasts

2003 • 39 citations

Characterizing the Protective Component of the αβ T Cell Response to Transplantable Squamous Cell Carcinoma

2004 • 37 citations

Chemical Carcinogens as Foreign Bodies and Some Pitfalls Regarding Cancer Immune Surveillance

2003 • 35 citations

Long-Term Suppression of Tumor Growth by TNF Requires a Stat1- and IFN Regulatory Factor 1-Dependent IFN-γ Pathway but Not IL-12 or IL-18

2004 • 26 citations

Vaccine-induced CD8+ T cells eliminate tumors by a two-staged attack

2003 • 22 citations

Response to 'A cancer immunosurveillance controversy'

2003 • 15 citations

Observations with tumour necrosis factor gene-transfected tumours.

1994 • 6 citations

Cited By (0)

Loading...
The role of tumor stroma in the interaction between tumor and immune system (2005) – Current Opinion in Immunology | Metascience Observatory Explorer